199
Participants
Start Date
September 6, 2017
Primary Completion Date
October 23, 2018
Study Completion Date
October 23, 2018
Placebo
Placebo matching to SPD489 (Lisdexamfetamine dimesylate) capsule for 6 weeks.
SPD489 (Lisdexamfetamine dimesylate)
SPD489 capsule in a 5:5:5:5:6 ratio to 5, 10, 20, 30 mg orally once daily for 6 weeks.
SPD489
SPD489
Manhattan Behavioral Medicine, New York
University of Rochester, Rochester
Kennedy Krieger Institute, Baltimore
Clinical Research Partners, LLC, Petersburg
Carolina Clinical Trials, Inc., Charleston
Coastal Carolina Research, Mt. Pleasant
Rainbow Research Inc, Barnwell
iResearch Atlanta LLC, Decatur
Clinical Neuroscience Solutions, Inc., Jacksonville
Sarkis Clinical Trials, Gainesville
Avail Clinical Research, LLC, DeLand
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions, Orlando
APG Research, LLC, Orlando
University of South Florida Department Of Psychiatry, Tampa
University of South Florida, St. Petersburg
Harmonex, Inc, Dothan
Clinical Neuroscience Solutions, Inc, Memphis
University Hospitals Case Medical Center, Cleveland
Pediatric Associates of Fairfield, Inc, Fairfield
Rochester Center for Behavioral Medicine, Rochester Hills
Clinical Neurophysiology Services, Sterling Heights
Washington University, St Louis
Premier Psychiatric Reseach Institute, LLC, Lincoln
Lake Charles Clinical Trials, Lake Charles
Preferred Research Partners, Inc, Little Rock
IPS Research Company, Oklahoma City
Oklahoma Clinical Research Center, Oklahoma City
Paradigm Research Professionals, Oklahoma City
Cutting Edge Research Group, Oklahoma City
Bayou City Research Limited, Houston
BI Research Center, Houston
Red Oak Psychiatry Associates, Houston
Family Psychiatry of the Woodlands, The Woodlands
Road Runner Research, San Antonio
BioBehavioral Research of Austin, Austin
Ericksen Research and Development, Clinton
Alliance for Wellness d/b/a Alliance for Research, Long Beach
Asclepes Research, Panorama City
Psychiatric Centers at San Diego, San Diego
Sun Valley Research Center, Imperial
CMB Clinical Trials, Colton
Elite Clinical Trials, Inc, Wildomar
UCSF Dept of Psychiatry, San Francisco
Cyn3rgy Research Center, Gresham
Northwest Clinical Research Center, Bellevue
Seattle Childrens Hospital, Pearl Clinic, Seattle
Jersey Shore University Medical Center (JSUMC), Neptune City
Lead Sponsor
Shire
INDUSTRY